Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway - Scorecard - MDSpire

Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway

  • By

  • Sophie Scholz

  • Julia Prinz

  • Linde Sevenants

  • Andrea Holzwarth

  • Birgit Mertens

  • Robert Pieper

  • Vera Ritz

  • Kirsten Schulz

  • Holger Sieg

  • Aswin Mangerich

  • Linda Böhmert

  • June 27, 2026

  • 0 min

Share

Clinical Scorecard: Copper Oxide Nanoparticles: Analyzing EU Regulations and Mechanistic Toxicity in Relation to Cuproptosis-Associated Adverse Outcome Pathways

At a Glance

CategoryDetail
ConditionCopper Oxide Nanoparticles
Key MechanismsCuproptosis and biological interactions of nanoparticles
Target PopulationGeneral population exposed to food and feed containing CuO and Cu2O nanoparticles
Care SettingRegulatory and safety assessment frameworks

Key Highlights

  • CuO and Cu2O nanoparticles are permitted in the EU for various applications.
  • Existing regulations do not uniformly differentiate between nanoforms and non-nanoforms.
  • Potential health hazards are influenced by exposure concentrations and biological interactions.
  • Cuproptosis is a newly recognized variant of regulated cell death linked to copper.
  • Regulatory frameworks need to address the unique properties of nanoparticles.

Guideline-Based Recommendations

Diagnosis

  • Include specific diagnostic criteria or guidelines related to copper nanoparticle exposure.

Management

  • Add management strategies for individuals exposed to copper nanoparticles.

Monitoring & Follow-up

  • Provide monitoring recommendations for at-risk populations.

Risks

    Patient & Prescribing Data

    ['Specify the types of risks associated with copper nanoparticles that current regulations fail to address.']

    Clinical Best Practices

    • Enhance regulatory definitions and categorizations for nanomaterials.
    • Conduct thorough risk assessments incorporating mechanistic understanding of copper nanoparticles.
    • Implement New Approach Methodologies (NAMs) in the evaluation of nanomaterials.

    Related Resources & Content

    Original Source(s)

    Related Content